HYZAAR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Losartan Potassium; Hydrochlorothiazide.
Product ID | 0006-0745_32622632-0367-4cc0-ae2e-21b02371dfcb |
NDC | 0006-0745 |
Product Type | Human Prescription Drug |
Proprietary Name | HYZAAR |
Generic Name | Losartan Potassium And Hydrochlorothiazide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1995-04-28 |
Marketing Category | NDA / NDA |
Application Number | NDA020387 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 100 mg/1; mg/1 |
Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1995-04-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020387 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-04-28 |
Marketing Category | NDA |
Application Number | NDA020387 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-04-28 |
Marketing Category | NDA |
Application Number | NDA020387 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-04-28 |
Marketing End Date | 2011-08-29 |
Marketing Category | NDA |
Application Number | NDA020387 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-04-28 |
Marketing End Date | 2011-08-29 |
Marketing Category | NDA |
Application Number | NDA020387 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1995-04-28 |
Marketing End Date | 2011-08-29 |
Marketing Category | NDA |
Application Number | NDA020387 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1995-04-28 |
Ingredient | Strength |
---|---|
LOSARTAN POTASSIUM | 100 mg/1 |
SPL SET ID: | d3e434b9-2f56-4dec-8cbf-a61e23abcc6a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0006-0717 | HYZAAR | losartan potassium and hydrochlorothiazide |
0006-0745 | HYZAAR | losartan potassium and hydrochlorothiazide |
0006-0747 | HYZAAR | losartan potassium and hydrochlorothiazide |
21695-788 | HYZAAR | HYZAAR |
43353-926 | HYZAAR | HYZAAR |
55289-522 | HYZAAR | HYZAAR |
63629-3183 | HYZAAR | HYZAAR |
0054-0126 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
0054-0127 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
0054-0277 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
0093-7367 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
0093-7368 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
0093-7369 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
0781-5816 | losartan potassium and hydrochlorothiazide | losartan potassium and hydrochlorothiazide |
0781-5817 | losartan potassium and hydrochlorothiazide | losartan potassium and hydrochlorothiazide |
0781-5818 | losartan potassium and hydrochlorothiazide | losartan potassium and hydrochlorothiazide |
13668-116 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HYZAAR 74431110 1917146 Live/Registered |
MERCK SHARP & DOHME CORP. 1993-09-01 |